Angelicin potentiates TRAIL ‐induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down‐regulation of c‐FLIP expression

This study provides evidence that angelicin might be a TRAIL sensitizer.

Source: Drug Development Research - September 1, 2017 Category: Drugs & Pharmacology Authors: Kyoung ‐Jin Min, Hee Jung Um, Seung Un Seo, Seon Min Woo, Shin Kim, Jong‐Wook Park, Hyun‐Shik Lee, Sang Hyun Kim, Yung Hyun Choi, Tae‐Jin Lee, Taeg Kyu Kwon Tags: Research Article Source Type: research